- Home
- GSBD vs BLFS Comparison
GSBD vs BLFS Comparison
Compare GSBD & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBD
- BLFS
- Stock Information
- Founded
- GSBD 2012
- BLFS 1987
- Country
- GSBD United States
- BLFS United States
- Employees
- GSBD N/A
- BLFS N/A
- Industry
- GSBD Finance: Consumer Services
- BLFS Medical/Dental Instruments
- Sector
- GSBD Finance
- BLFS Health Care
- Exchange
- GSBD Nasdaq
- BLFS Nasdaq
- Market Cap
- GSBD 1.4B
- BLFS 1.2B
- IPO Year
- GSBD N/A
- BLFS 1989
- Fundamental
- Price
- GSBD $10.83
- BLFS $23.29
- Analyst Decision
- GSBD Sell
- BLFS Strong Buy
- Analyst Count
- GSBD 2
- BLFS 7
- Target Price
- GSBD $12.00
- BLFS $30.57
- AVG Volume (30 Days)
- GSBD 695.5K
- BLFS 573.8K
- Earning Date
- GSBD 05-08-2025
- BLFS 05-08-2025
- Dividend Yield
- GSBD 17.66%
- BLFS N/A
- EPS Growth
- GSBD N/A
- BLFS N/A
- EPS
- GSBD 0.45
- BLFS N/A
- Revenue
- GSBD $419,771,000.00
- BLFS $87,762,000.00
- Revenue This Year
- GSBD N/A
- BLFS $20.32
- Revenue Next Year
- GSBD N/A
- BLFS $19.98
- P/E Ratio
- GSBD $24.37
- BLFS N/A
- Revenue Growth
- GSBD N/A
- BLFS N/A
- 52 Week Low
- GSBD $9.51
- BLFS $17.15
- 52 Week High
- GSBD $15.94
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- GSBD 50.22
- BLFS 49.30
- Support Level
- GSBD $10.42
- BLFS $21.13
- Resistance Level
- GSBD $10.60
- BLFS $25.60
- Average True Range (ATR)
- GSBD 0.21
- BLFS 1.58
- MACD
- GSBD 0.07
- BLFS -0.07
- Stochastic Oscillator
- GSBD 66.93
- BLFS 48.32
About GSBD Goldman Sachs BDC Inc.
Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests primarily in U.S. middle-market companies such as banks and the public debt markets. The company's origination strategy focuses on leading the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.